Verde Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-42,837
Closed -$2.96M 71
2025
Q2
$2.96M Buy
42,837
+5,639
+15% +$384K 0.73% 29
2025
Q1
$2.58M Buy
37,198
+13,294
+56% +$1.1M 0.73% 28
2024
Q4
$2.06M Buy
23,904
+12,815
+116% +$1.39M 0.58% 29
2024
Q3
$1.32M Buy
+11,089
New +$1.48M 0.4% 34

Other funds holding NVO

Verde Capital Management's NVO Position: Q3 2025 in Review

Verde Capital Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 42,837 shares — an estimated $2.96M sold.

Verde Capital Management first reported a position in NVO in Q3 2024 and held it in 4 quarters. The position peaked at $2.96M in Q2 2025. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Verde Capital Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Verde Capital Management sold 42,837 Novo Nordisk shares in Q3 2025, an estimated $2.96M.
  • Verde Capital Management first reported a position in Novo Nordisk in Q3 2024 and held it in 4 quarters.
  • Verde Capital Management's Novo Nordisk position peaked at $2.96M in Q2 2025.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Verde Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.